Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Rt2: computing and visualising COVID-19 epidemics temporal reproduction number

View ORCID ProfileBastien Reyné, View ORCID ProfileGonché Danesh, View ORCID ProfileSamuel Alizon, View ORCID ProfileMircea T. Sofonea
doi: https://doi.org/10.1101/2020.12.05.20244376
Bastien Reyné
1MIVEGEC, CNRS, IRD, Université de Montpellier, 911 avenue Agropolis, 34394 Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bastien Reyné
Gonché Danesh
1MIVEGEC, CNRS, IRD, Université de Montpellier, 911 avenue Agropolis, 34394 Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gonché Danesh
Samuel Alizon
1MIVEGEC, CNRS, IRD, Université de Montpellier, 911 avenue Agropolis, 34394 Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samuel Alizon
Mircea T. Sofonea
2MIVEGEC, Université de Montpellier, CNRS, IRD, 911 avenue Agropolis, 34394 Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mircea T. Sofonea
  • For correspondence: mircea.sofonea@umontpellier.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Analysing the spread of COVID-19 epidemics in a timely manner is essential for public health authorities. However, raw numbers may be misleading because of spatial and temporal variations. We introduce Rt2, an R-program with a shiny interface, which uses incidence data, i.e. number of new cases per day, to compute variations in the temporal reproduction number (ℛt), which corresponds to the average number of secondary infections caused by an infected person. This number is computed with the R0 package, which better captures past variations, and the EpiEstim package, which provides a more accurate estimate of current values. ℛt can be computed in different countries using either the daily number of new cases or of deaths. For France, these numbers can also be computed at the regional and departmental level using also daily numbers of hospital and ICU admissions. Finally, in addition to ℛt, we represent the incidence using a one-week sliding window to buffer daily variations. Overall, Rt2 provides an accurate and timely overview of the state and speed of spread of COVID-19 epidemics at different scales, using different metrics.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was partly supported by the Occitanie region and the ANR (PHYEPI project). GD is funded by the Fondation pour la Recherche Médicale (FRM grant number ECO20170637560).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The present methodological work is solely based on computational analysis of publicly available data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • bastien.reyne{at}ird.fr

    gonche.danesh{at}ird.fr

    samuel.alizon{at}cnrs.fr

    mircea.sofonea{at}umontpellier.fr

Data Availability

All the data used in this study are publicly available.

https://bioinfo-shiny.ird.fr/Rt2-en/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 07, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Rt2: computing and visualising COVID-19 epidemics temporal reproduction number
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Rt2: computing and visualising COVID-19 epidemics temporal reproduction number
Bastien Reyné, Gonché Danesh, Samuel Alizon, Mircea T. Sofonea
medRxiv 2020.12.05.20244376; doi: https://doi.org/10.1101/2020.12.05.20244376
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Rt2: computing and visualising COVID-19 epidemics temporal reproduction number
Bastien Reyné, Gonché Danesh, Samuel Alizon, Mircea T. Sofonea
medRxiv 2020.12.05.20244376; doi: https://doi.org/10.1101/2020.12.05.20244376

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (48)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4861)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (676)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (630)
  • Health Policy (321)
  • Health Systems and Quality Improvement (206)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5343)
  • Intensive Care and Critical Care Medicine (331)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (686)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (208)
  • Oncology (440)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (90)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (781)
  • Public and Global Health (1817)
  • Radiology and Imaging (325)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)